Journal: Cell & bioscience
Article Title: Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation.
doi: 10.1186/s13578-025-01376-z
Figure Lengend Snippet: Fig. 6 ER stress enhances NLRP3 inflammasome activation in clusterin-KO primary HCs and KCs (A, B) Representative real-time RT-PCR analysis of NLRP3, IL1β, TNFα, and IL6 mRNA levels in clusterin-KO primary KCs (A) and HCs (B) treated with Tg (1 μM, 24 h). *p < 0.05, **p < 0.01, ***p < 0.001. (C) ELISA of IL1β levels in clusterin-KO primary HCs and KCs treated with Tg (1 μM, 24 h). *p < 0.05, ***p < 0.001. (D) Representative western blot analysis of NLRP3 and IL1β protein expression in lysates of clusterin-KO primary HCs and KCs treated with Tg
Article Snippet: Antibodies against clusterin (SC6420), CHOP (SC7351), ATF6 (SC166659), CTGF (SC365970) and ASC (SC514414) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
Techniques: Activation Assay, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Western Blot, Expressing